D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
FATE holding history
Fate Therapeutics Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FATE overviewAll 13F holders of FATEFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −433,192−100.0% | Sold out | Holders |
| Q1 2025 | 433,192 | $342.3K | <0.1% | −1,103,441−71.8% | Reduced | Holders |
| Q4 2024 | 1,536,633 | $2.54M | <0.1% | −1,841,017−54.5% | Reduced | Holders |
| Q3 2024 | 3,377,650 | $11.8M | <0.1% | −700,272−17.2% | Reduced | Holders |
| Q2 2024 | 4,077,922 | $13.4M | <0.1% | +1,346,956+49.3% | Added | Holders |
| Q1 2024 | 2,730,966 | $20.0M | <0.1% | −851,013−23.8% | Reduced | Holders |
| Q4 2023 | 3,581,979 | $13.4M | <0.1% | −1,129,685−24.0% | Reduced | Holders |
| Q3 2023 | 4,711,664 | $9.99M | <0.1% | +112,225+2.4% | Added | Holders |
| Q2 2023 | 4,599,439 | $21.9M | <0.1% | +1,634,197+55.1% | Added | Holders |
| Q1 2023 | 2,965,242 | $16.9M | <0.1% | +2,707,319+1,049.7% | Added | Holders |
| Q4 2022 | 257,923 | $2.60M | <0.1% | +257,923 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −17,821−100.0% | Sold out | Holders |
| Q3 2021 | 17,821 | $1.06M | <0.1% | −65,727−78.7% | Reduced | Holders |
| Q2 2021 | 83,548 | $7.25M | <0.1% | −222,690−72.7% | Reduced | Holders |
| Q1 2021 | 306,238 | $25.2M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.